Hims & Hers Stock Surges 13% on FDA Peptide Review Optimism and Telehealth Momentum

Source: International Business Times

hims & hers Shares of Hims & Hers Health Inc. climbed sharply in morning trading Friday as investors bet that potential regulatory relief on compounded peptides could strengthen the telehealth company's weight-loss offerings and broader platform growth. At 11:15 a.